Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart van Hoek

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 5, 2003
Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytesW Rogier ten Hove, Bart van Hoek, Ingeborg M Bajema, et al.
British Journal of Clinical Pharmacology|March 31, 2021
Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipientsLisa C Martial, Maaike Biewenga, Bastian N Ruijter, et al.
Annals of Hepatology|November 7, 2025
Aspartate aminotransferase‑to‑platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitisMartine A M C Baven-Pronk, Camiel J M Marijnissen, Maaike Biewenga, et al.
European Journal of Clinical Pharmacology|December 23, 2022
Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulationLaure Ponthier, Pierre Marquet, Dirk Jan A R Moes, et al.
British Journal of Health Psychology|May 6, 2017
Trajectories of anxiety and depression in liver transplant candidates during the waiting-list periodCoby Annema, Petrie F Roodbol, Edwin R Van den Heuvel, et al.
Drug Safety|April 22, 2016
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentElise J Smolders, Clara T M M de Kanter, Bart van Hoek, et al.
Clinical Transplantation|July 25, 2025
Addition of a Temporary Portocaval Shunt Does Not Reduce Acute Kidney Injury in Caval-Sparing Liver TransplantationLars C Pietersen, Niels Broekman, Marije Reekers, et al.
Psychosomatic Medicine|November 8, 2017
Trajectories of Anxiety and Depression After Liver Transplantation as Related to Outcomes During 2-Year Follow-Up: A Prospective Cohort StudyCoby Annema, Gerda Drent, Petrie F Roodbol, et al.
Journal of Psychosomatic Research|February 11, 2017
A prospective cohort study on posttraumatic stress disorder in liver transplantation recipients before and after transplantation: Prevalence, symptom occurrence, and intrusive memoriesCoby Annema, Gerda Drent, Petrie F Roodbol, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2019
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantationIris C Steenstraten, Kerem Sebib Korkmaz, Palak J Trivedi, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 5, 2003
Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytesW Rogier ten Hove, Bart van Hoek, Ingeborg M Bajema, et al.
British Journal of Clinical Pharmacology|March 31, 2021
Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipientsLisa C Martial, Maaike Biewenga, Bastian N Ruijter, et al.
Annals of Hepatology|November 7, 2025
Aspartate aminotransferase‑to‑platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitisMartine A M C Baven-Pronk, Camiel J M Marijnissen, Maaike Biewenga, et al.
European Journal of Clinical Pharmacology|December 23, 2022
Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulationLaure Ponthier, Pierre Marquet, Dirk Jan A R Moes, et al.
British Journal of Health Psychology|May 6, 2017
Trajectories of anxiety and depression in liver transplant candidates during the waiting-list periodCoby Annema, Petrie F Roodbol, Edwin R Van den Heuvel, et al.
Drug Safety|April 22, 2016
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentElise J Smolders, Clara T M M de Kanter, Bart van Hoek, et al.
Clinical Transplantation|July 25, 2025
Addition of a Temporary Portocaval Shunt Does Not Reduce Acute Kidney Injury in Caval-Sparing Liver TransplantationLars C Pietersen, Niels Broekman, Marije Reekers, et al.
Psychosomatic Medicine|November 8, 2017
Trajectories of Anxiety and Depression After Liver Transplantation as Related to Outcomes During 2-Year Follow-Up: A Prospective Cohort StudyCoby Annema, Gerda Drent, Petrie F Roodbol, et al.
Journal of Psychosomatic Research|February 11, 2017
A prospective cohort study on posttraumatic stress disorder in liver transplantation recipients before and after transplantation: Prevalence, symptom occurrence, and intrusive memoriesCoby Annema, Gerda Drent, Petrie F Roodbol, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2019
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantationIris C Steenstraten, Kerem Sebib Korkmaz, Palak J Trivedi, et al.
Pageof 19